ArticleGynecologic oncology reports2025

Retreatment with PARPi following stem cell transplant in a patient with recurrent ovarian cancer and myelodysplastic syndrome.

Shilpa Mokshagundam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.